Virtu Financial’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALLO
Virtu Financial's ALLO Position: Q3 2026 in Review
Virtu Financial sold out of Allogene Therapeutics (ALLO) in Q3 2026, closing a stake of 97,591 shares — an estimated $203K sold.
Virtu Financial first reported a position in ALLO in Q3 2019 and held it in 9 quarters. The position peaked at $532K in Q4 2021. 198 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.
- Virtu Financial reported no remaining Allogene Therapeutics position as of Q3 2026 after selling out during the quarter.
- Virtu Financial sold 97,591 Allogene Therapeutics shares in Q3 2026, an estimated $203K.
- Virtu Financial first reported a position in Allogene Therapeutics in Q3 2019 and held it in 9 quarters.
- Virtu Financial's Allogene Therapeutics position peaked at $532K in Q4 2021.
- 198 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.